CV Sciences Inc (OTCMKTS:CVSI) Communicates To Shareholders Through A Letter

CV Sciences Inc (OTCMKTS:CVSI) Communicates To Shareholders Through A Letter

CV
Sciences Inc (OTCMKTS:CVSI)

is pleased with its PlusCBD™ Oil brand and the way it has
dominated the market. The company’s CEO, Joseph Dowling, today released a
letter to the company’s shareholders in this regard. It was a week ago that the
business guru unveiled its second quarter results. Dowling thanked all the
stakeholders for the role they played to help the company report a high
quarterly revenue. This was the highest peak since the company’s establishment.
CV Sciences has
achieved sequential revenue growth over14
consecutive quarters.

Dowling’s thoughts regarding the
matter

Dowling
attributes the consistent growth to the company’s product, the PlusCBD™ Oil
brand. He adds that the company has also taken a notch higher its distribution
activities, selling its wide range of products to more retail outlets. Every
year, the company manages almost to double its retail outlets. That means
higher sales of the product.
CV Sciences continues enjoying increased selling opportunities.

The company’s CEO believes that the
fundamentals that guide the company are appropriate. They are the reason they
can serve the fast-expanding market for the hemp-based CBD products.
The official applauds the company’s second quarter results and anticipates a
brighter future.

Dowling and other leaders’ reservations
and plans

However,
the CEO expresses his dissatisfaction with certain aspects of the market
reaction.

According
to the official, the company has all along dedicated itself to giving timely
quarterly updates. As a result, the company has been facing massive
competition. Leaders in the company have expressed fears over a reduction in
the quarterly revenues. They feel that something needs to be done to stop the
choppy quarterly results that may be experienced over consecutive quarters.

The
encouraging aspect is this company’s determination on not getting detracted at
all. The company will continue taking advantage of the fast-growing market
opportunities. It will also be hoping to expand its distributions activities
further.

CV Sciences says it will continue
investing in its brand to make it more accessible and also for profitability
sake. The business giant says it will stop at nothing towards upholding the
current growth trajectory. Strengthening the PlusCBD™
Oil brand remains the company’s topmost priority at the moment.

Published at Fri, 23 Aug 2019 12:01:32 +0000

Post a Comment

Your email address will not be published. Required fields are marked *

*